Fan, Aoyuan
Wu, Genbin
Wang, Jianfang
Lu, Laiya
Wang, Jingyi
Wei, Hanjing
Sun, Yuxi
Xu, Yanhua
Mo, Chunyang
Zhang, Xiaoying
Pang, Zhiying
Pan, Zhangyi
Wang, Yiming
Lu, Liangyu
Fu, Guojian
Ma, Mengqiu
Zhu, Qiaoling
Cao, Dandan
Qin, Jiachen
Yin, Feng
Yue, Rui http://orcid.org/0000-0002-3401-369X
Article History
Received: 19 January 2022
Revised: 14 October 2022
Accepted: 11 November 2022
First Online: 2 January 2023
Competing interests
: R.Y., A.F. and F.Y. have filed a provisional patent on the use of Fap inhibitors as anti-osteoarthritis drugs. The other authors declare no competing interests.
: All human samples were collected in accordance with the ethical guidelines and protocols approved by the Ethics Committee of Shanghai East Hospital. Written informed consent was obtained from all patients before sample collection. All animal procedures were approved by the Tongji University Animal Care and Use Committee.